Co- infectious Cytomegalovirus and Pneumocystis Jiroveci Pneumonia in a Polyarteritis Nodosa Patient: A Case Report

Document Type : Case Report


1 Residency of internal Medicine, Lung Diseases Research Center, Mashhad University of Medical Sciences

2 Pulmonologist, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Our report discusses a patient diagnosed with PAN since 3 years ago. He presented with fever, chills and nonproductive cough. He was a long time receiver of immunosuppressant drugs for his underlying condition. Upon examination he was febrile, had cushingoid appearance and cackles in both lungs. Lung CT scan showed opacities in right upper lobe lung and multiple bilateral nodules and ground glass opacity along with mild thickening of pleura. A bronchoscopy was ordered to asses PCP, and without hesitation empirical therapy was started. However, his clinical condition did not improve as expected. At this time, suspecting another infection at play, a PCR and BAL specimen was ordered for CMV. After receiving the result of BAL analysis, our suspicion was confirmed for both PCP and CMV pneumonia. CMV is an important opportunistic infection in immunocompromised individuals. This case highlights this importance in immunocompromising conditions. In this setting, presence of respiratory signs and symptoms point out to PCP as the first differential diagnosis; but at the same time it’s crucial for clinicians to consider the possibility of CMV as a co-infective agent.


  1. Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. Journal of autoimmunity. 2014;48:84-9.
  2. Meyer MF, Hellmich B, Kotterba S, Schatz H. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection? Rheumatology international. 2000;20(1):35-8.
  3. Sunnetcioglu A, Sunnetcioglu M, Emre H, Soyoral L, Goktas U. Cytomegalovirus pneumonia and pulmonary haemorrhage in a patient with polyarteritis nodosa. JPMA The Journal of the Pakistan Medical Association. 2016;66(11):1484-6.
  4. Bungo MW, Beetham WP, Jr. Arthritis rounds. Pneumocystis carinii associated with polyarteritis and immunosuppressive therapy. Arthritis and rheumatism. 1977;20(5):1142-6.
  5. Hedderwick SA, Bonilla HF, Bradley SF, Kauffman CA. Opportunistic infections in patients with temporal arteritis treated with corticosteroids. 1997.
  6. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. American journal of respiratory and critical care medicine. 1995;151(3):795-9.
  7. Sendi P, Wolf A, Graber P, Zimmerli W. Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog. Scandinavian journal of infectious diseases. 2006;38(10):922-4.
  8. Merigan TC. Immunosuppression and herpesviruses. In: NahmiasAJ DW, Schinazi RF editors, The human herpesviruses:an interdisciplinary perspective. New York: Elsevier, 1981:309–22.
  9. Simon D, Greyling K, Irusen E, Rigby J, Taljaard J, Koegelenberg C. Pneumocystis jiroveci and Cytomegalovirus co-infection in an immunocompromised patient. African Journal of Thoracic and Critical Care Medicine. 2016;22(1):20-1.
  10. Shah K, Cherabuddi K, Beal SG, Kalyatanda G. Refractory acute respiratory failure due to Pneumocystis jiroveci (PCP) and Cytomegalovirus (CMV) pneumonitis: A case report and review of literature. IDCases. 2017;10:42-5.
  11.  Jensen A-MB, Lundgren JD, Benfield T, Nielsen TL, Vestbo J. Does Cytomegalovirus Predict a Poor Prognosis in Pneumocystis carinii Pneumonia Treated With Corticosteroids?: A Note for Caution. Chest. 1995;108(2):411-4.
  12. Vetter M, Battegay M, Trendelenburg M. Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. Infection. 2010;38(4):331-4.